Miliaris develops Amygdala, a focused application with a documented exposure pattern centered on cross-site scripting vulnerabilities arising from improper input neutralization in web page generation. Current severity, exploitation, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Miliaris over time
Signals from CVEs in this vendor scope (3 CVEs).
3 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2025-45880MEDIUM A cross-site scripting (XSS) vulnerability in the data resource management function of Miliaris Amigdala v2.2.6 allows attackers to execute arbitrary HTML in the context of a user' | Jun 17, 2025 | 6.1 | 18 | NO | NO |
CVE-2025-45878MEDIUM A cross-site scripting (XSS) vulnerability in the report manager function of Miliaris Amigdala v2.2.6 allows attackers to execute arbitrary HTML in the context of a user's browser | Jun 17, 2025 | 6.1 | 18 | NO | NO |
CVE-2025-45879MEDIUM A cross-site scripting (XSS) vulnerability in the e-mail manager function of Miliaris Amigdala v2.2.6 allows attackers to execute arbitrary HTML in the context of a user's browser | Jun 17, 2025 | 6.1 | 18 | NO | NO |
Signals from CVEs in this vendor scope (3 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Miliaris.
Media articles that mention a CVE ID that affects a product developed by Miliaris — matched by CVE ID, not by vendor name.